› › Buying Rx Drugs Online

Buying Rx Drugs Online

Author : Kate Chase

Publisher : Course Technology

Page : 324 pages

File Size : 45,1 MB

Release : 2005

Category : Computers

ISBN : 9781592006717

Get eBook

Book Description

The Internet can provide several cost-saving alternatives for the purchase of prescription drugs. Without adequate information, however, it can also be a dangerous alternative. Buying Rx Drugs Online serves as a smart consumer guide for anyone who is considering going online for medications. It covers the full range of the online pharmaceutical experience, explaining both the benefits and the dangers, as well as why medical professionals should be kept in the loop. It examines the convenience and consequences of buying prescription-and even some non-prescription-medication through the Internet. It offers valuable tips and advice regarding what to look for in judging the legitimacy of these sites and how you can verify the medications you receive.



Making Medicines Affordable

Author : National Academies of Sciences, Engineering, and Medicine

Publisher : National Academies Press

Page : 235 pages

File Size : 44,91 MB

Release : 2018-03-01

Category : Medical

ISBN : 0309468086

Get eBook

Book Description

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.



Countering the Problem of Falsified and Substandard Drugs

Author : Institute of Medicine

Publisher : National Academies Press

Page : 377 pages

File Size : 22,25 MB

Release : 2013-06-20

Category : Medical

ISBN : 0309269393

Get eBook

Book Description

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.



Pain Management and the Opioid Epidemic

Author : National Academies of Sciences, Engineering, and Medicine

Publisher : National Academies Press

Page : 483 pages

File Size : 27,61 MB

Release : 2017-09-28

Category : Medical

ISBN : 0309459575

Get eBook

Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.



Healthcare Heroes

Author : Mary Choy

Publisher :

Page : 242 pages

File Size : 45,49 MB

Release : 2020

Category : Medical education

ISBN : 9781905941315

Get eBook

Book Description

This book provides expert insights and strategies to help readers find their best career path in healthcare. It features healthcare professionals and their stories, giving unfiltered, unedited, no holds barred version of what it’s really like to be a healthcare professional in the 21st century.



PBMs

Author : Sheila Shulman

Publisher : CRC Press

Page : 216 pages

File Size : 16,24 MB

Release : 1998-06-18

Category : Medical

ISBN : 9780789005120

Get eBook

Book Description

PBMs: Reshaping the Pharmaceutical Distribution Network provides HMOs and other third-party payers with information on the new and increasingly important role of pharmaceutical benefit companies (PBMs) in the health care industry. From this text, you will learn how PBMs can maintain and deliver a quality, cost-effective drug benefit plan to your company while achieving the anticipated market share for the product. PBMs: Reshaping the Pharmaceutical Distribution Network offers you suggestions on how to choose which PBM service is correct for your business, such as what qualifications to look for in a PBM, as well as what questions you should ask a respective company. This text also offers ways on how your company can benefit from becoming a client and may make your business more competitive in the pharmaceutical industry. PBMs: Reshaping the Pharmaceutical Distribution Network also informs you about the controversies that have arisen concerning the new position of PBMs in the industry. Through research and evaluation, this text addresses these issues from many different perspectives and gives you insight into other topics concerning PBMs, including: operating methods that PBMs currently rely on for designing and overseeing a drug benefit plan how the Food and Drug Administration currently views the role of PBMs and why they are contemplating regulatory intervention alerting PBMs, pharmacies, pharmaceutical companies, and managed care organizations to new legal issues involving fraud and abuse affecting pharmacy benefit management and pharmaceutical manufacturers reasons why retail drug chains and pharmacist organizations oppose recent industry developments regarding PBMs whether or not PBMs reflect a move toward greater centralized decisionmaking in the health care systemIn addition, PBMs: Reshaping the Pharmaceutical Distribution Network offers pharmaceutical companies, health care providers, and managed care organizations several suggestions for further research, which may make your business or your business relationships more efficient and productive in the future. If you or your company are considering the services of a pharmacy benefit management, PBMs: Reshaping the Pharmaceutical Distribution Network will guide you in choosing a company that helps you deliver the most cost-effective and efficient pharmaceutical benefits to customers.



The Pill Book

Author : Gilbert I. Simon

Publisher : Bantam

Page : 980 pages

File Size : 49,1 MB

Release : 1990-01-01

Category : Drugs

ISBN : 9780553346787

Get eBook

Book Description

Revised for its tenth edition, "The Pill Book" remains the bestselling and and most trusted consumer reference to the most-prescribed drugs in the United States. 32-page color insert. Copyright © Libri GmbH. All rights reserved.



The Peaceful Pill Handbook

Author : Philip Nitschke

Publisher : Exit International US Ltd

Page : 216 pages

File Size : 40,15 MB

Release : 2006-09

Category : Medical

ISBN : 0978878809

Get eBook

Book Description



This Machine Kills Secrets

Author : Andy Greenberg

Publisher : Penguin

Page : 392 pages

File Size : 38,24 MB

Release : 2012-09-13

Category : Computers

ISBN : 110159358X

Get eBook

Book Description

At last, the first full account of the cypherpunks who aim to free the world’s institutional secrets, by Forbes journalist Andy Greenberg who has traced their shadowy history from the cryptography revolution of the 1970s to Wikileaks founding hacker Julian Assange, Anonymous, and beyond. WikiLeaks brought to light a new form of whistleblowing, using powerful cryptographic code to hide leakers’ identities while they spill the private data of government agencies and corporations. But that technology has been evolving for decades in the hands of hackers and radical activists, from the libertarian enclaves of Northern California to Berlin to the Balkans. And the secret-killing machine continues to evolve beyond WikiLeaks, as a movement of hacktivists aims to obliterate the world’s institutional secrecy. This is the story of the code and the characters—idealists, anarchists, extremists—who are transforming the next generation’s notion of what activism can be. With unrivaled access to such major players as Julian Assange, Daniel Domscheit-Berg, and WikiLeaks’ shadowy engineer known as the Architect, never before interviewed, reporter Andy Greenberg unveils the world of politically-motivated hackers—who they are and how they operate.



China Rx

Author : Rosemary Gibson

Publisher : Prometheus Books

Page : 306 pages

File Size : 32,82 MB

Release : 2018

Category : Business & Economics

ISBN : 1633883817

Get eBook

Book Description

Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers. Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This is a disturbing, well-researched book and a wake-up call for improving the current system of drug supply and manufacturing.